The impact goal of SP26–31 is to improve health and well-being for all throughout the Region. Its achievement requires concerted action by Member States in collaboration with PASB and partners, implementing integrated approaches across the strategic objectives and tailored interventions in countries to reduce health disparities. It is proposed that the goal be measured through a suite of 17 impact indicators along with proposed baselines and targets, addressing both the improvement of health systems and their sustainability, as well as their social determinants. These impact indicators will also be used to report on the Organization’s contribution to collective achievement of the SHAA2030 goals and the Region’s contribution toward global health targets. The definition of the indicators considered lessons learned from SP20–25 and commitments already made by Member States, including in the SHAA2030, and PAHO Governing Bodies mandates. Technical specifications, including definitions of terms, technical criteria, and sources, are available to ensure clarity and consistency in their application for monitoring and evaluation.
SP 2026-2031
Impact Goal

Overview
Indicator | SP20–25 | SHAA 2030 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Reduction of within-country health inequalities |
✓
|
11.1
|
||||||||||||
|
||||||||||||||
2. Mortality rate attributed to household and ambient air pollution |
✓
|
11.3
|
||||||||||||
|
||||||||||||||
3. Mortality rate attributed to unsafe water, unsafe sanitation, and lack of hygiene |
✓
|
11.3
|
||||||||||||
|
||||||||||||||
4. Health-adjusted life expectancy |
✓
|
All
|
||||||||||||
|
||||||||||||||
5. Neonatal mortality rate |
✓
|
1.3
|
||||||||||||
|
||||||||||||||
6. Maternal mortality ratio |
✓
|
1.2
|
||||||||||||
|
||||||||||||||
7. Mortality amenable to health care |
✓
|
1.1
|
||||||||||||
|
||||||||||||||
8. Unconditional probability of dying between the ages of 30 and 70 from cardiovascular diseases, cancer, diabetes, or chronic respiratory diseases |
✓
|
9.1
|
||||||||||||
|
||||||||||||||
9. Mortality rate due to cervical cancer |
✓
|
9.1
|
||||||||||||
|
||||||||||||||
10. Proportion of ever-partnered women and girls aged 15–49 subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months* |
✓
|
9.4
|
||||||||||||
|
||||||||||||||
11. Mortality rate due to suicide |
✓
|
9.6
|
||||||||||||
|
||||||||||||||
12. Mortality rate due to road traffic injuries |
✓
|
9.5
|
||||||||||||
|
||||||||||||||
13. Incidence rate of HIV infections |
✓
|
10.1
|
||||||||||||
|
||||||||||||||
14. Incidence rate of congenital syphilis (including stillbirths) |
✓
|
10.3
|
||||||||||||
|
||||||||||||||
15. Incidence rate of tuberculosis |
✓
|
10.2
|
||||||||||||
|
||||||||||||||
16. Number of endemic countries that achieve elimination of malaria |
✓
|
10.6
|
||||||||||||
|
||||||||||||||
17. Number of countries and territories that maintain elimination certification for wild polio, rubella and congenital rubella syndrome, and measles |
N/A
|
10.4
|
||||||||||||
|
||||||||||||||
* While recognizing data challenges, Member States requested inclusion of this indicator with a commitment to build national capacity to generate the data for its measurement.